SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018839
Filing Date
2019-05-13
Accepted
2019-05-13 16:21:33
Documents
44
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20190331.htm 10-Q 1536852
2 EX-31.1 eq-ex311_8.htm EX-31.1 14272
3 EX-31.2 eq-ex312_6.htm EX-31.2 14361
4 EX-32.1 eq-ex321_7.htm EX-32.1 7270
  Complete submission text file 0001564590-19-018839.txt   4081045

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eq-20190331.xml EX-101.INS 800040
6 XBRL TAXONOMY EXTENSION SCHEMA eq-20190331.xsd EX-101.SCH 25480
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20190331_cal.xml EX-101.CAL 27660
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20190331_def.xml EX-101.DEF 64263
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20190331_lab.xml EX-101.LAB 192764
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20190331_pre.xml EX-101.PRE 143882
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 108 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 19818647
SIC: 2834 Pharmaceutical Preparations